A Single Center Phase II Assessor-Blinded RaNdomised Active Controlled Parallel-Group Trial to COmpare Ticagrelor Versus Clopidogrel on the REduction of ArteriaL STiffness and Wave Reflections in Patients With CoronarY Artery Disease.
Phase of Trial: Phase II
Latest Information Update: 20 Jun 2019
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Pharmacodynamics
- Acronyms NOVELTY
- 06 Sep 2018 Status changed from recruiting to completed.
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology
- 01 Mar 2017 Planned End Date changed from 1 Dec 2015 to 1 Jun 2017.